These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9759624)

  • 1. A heparin-coated circuit maintains platelet aggregability in response to shear stress in an in vitro model of cardiopulmonary bypass.
    Hioki I; Nishikawa M; Onoda K; Shimono T; Shimpo H; Tanaka K; Suzuki Y; Shiku H; Ikeda Y; Yada I
    Thromb Haemost; 1998 Sep; 80(3):437-42. PubMed ID: 9759624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin influences human platelet behavior in cardiac surgery with or without cardiopulmonary bypass.
    Laga S; Bollen H; Arnout J; Hoylaerts M; Meyns B
    Artif Organs; 2005 Jul; 29(7):541-6. PubMed ID: 15982282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of glycoprotein Ib in heparin coated and nonheparin coated extracorporeal circulation circuits.
    Hioki I; Yada I; Nishikawa M; Shomura Y; Cruz BP; Onoda K; Tani K; Shimono T; Shinpo H
    ASAIO J; 1998; 44(5):M397-400. PubMed ID: 9804459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist.
    Wang WJ; Huang TF
    Thromb Haemost; 2001 Oct; 86(4):1077-86. PubMed ID: 11686327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibiting effects of Ilexonin A on von Willebrand factor-dependent platelet aggregation under high shear rate.
    Li M; Wu WK; Liu L; Liao FL; Shinohara Y; Handa S; Goto S
    Chin Med J (Engl); 2004 Feb; 117(2):241-6. PubMed ID: 14975210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a silicone coated hollow fiber oxygenator.
    Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
    ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V.
    Kang M; Wilson L; Kermode JC
    Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell aggregation during cardiopulmonary bypass: a pathogenic cofactor in endothelial cell activation?
    Morariu AM; Gu YJ; Huet RC; Siemons WA; Rakhorst G; Oeveren WV
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):939-46. PubMed ID: 15519186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass.
    Muriithi EW; Belcher PR; Rao JN; Chaudhry MA; Nicol D; Wheatley DJ
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):538-43. PubMed ID: 10962416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
    Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
    Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A G-quartet oligonucleotide blocks glycoprotein Ib-mediated platelet adhesion and aggregation under flow conditions.
    Zhou Z; Bernardo A; Zhu Q; Guan Y; Sun W; Lopez JA; Jing N; Dong JF
    Thromb Haemost; 2009 Sep; 102(3):529-37. PubMed ID: 19718474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
    Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
    Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
    Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
    Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
    Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
    Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
    Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin ablates force development during platelet mediated clot retraction.
    Carr ME; Carr SL; Greilich PE
    Thromb Haemost; 1996 Apr; 75(4):674-8. PubMed ID: 8743198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-glycoprotein Ib causes platelet aggregation: different effects of blocking glycoprotein Ib and glycoprotein IIb/IIIa in the high shear filterometer.
    O'Brien JR; Etherington MD
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):453-61. PubMed ID: 9818994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.